毛霉菌病诊治新进展  

Progress in diagnosis and treatment of mucormycosis

作　　者：马路园 董宇飞 申川[1] 王亚东[1] 赵彩彦[1] Ma Luyuan;Dong Yufei;Shen Chuan;Wang Yadong;Zhao Caiyan(Department of Infectious Disease,the Third Hospital of Hebei Medical University,Shijiazhuang 050051,China;Department of Orthopedics,the First Hospital of Hebei Medical University,Shijiazhuang 050031,China)

机构地区：[1]河北医科大学第三医院感染科,石家庄050051 [2]河北医科大学第一医院骨科,石家庄050031

出　　处：《国际流行病学传染病学杂志》2023年第2期145-149,共5页International Journal of Epidemiology and Infectious Disease

基　　金：河北省重点研发计划(20277702D);河北省感染性疾病临床医学研究中心创新能力提升项目(20577704D)。

摘　　要：随着人口老龄化、免疫抑制人群增多和既往致命性疾病患者生存率的提高,毛霉菌病的发病率逐渐上升。全球范围内毛霉菌病负担较重,但我们对其认知较少。本文总结毛霉菌病的流行现状、易感因素、发病机制以及临床特点,重点关注新诊断及治疗策略,辅助临床及时识别并有效控制毛霉菌病的进展。The incidence of mucormycosis has gradually increased with the aging population,the increase in the immunosuppressed population,and improved survival of patients with a previously fatal disease.The global burden of mucormycosis is high,and there is limited understanding of this disease.In this paper,the prevalence,susceptible factors,pathogenesis and clinical characteristics of mucormycosis are summarized,especially new diagnosis and treatment strategies,so as to assist timely detection and effective control of mucormycosis.

关 键 词：毛霉菌病 发病机制 临床 诊断 治疗 流行 

分 类 号：R519[医药卫生—内科学]